HLA class I serotypes and cytotoxic T-lymphocyte responses among human immunodeficiency virus-1-uninfected Thai volunteers immunized with ALVAC-HIV in combination with monomeric gp120 or oligomeric gp160 protein boosting
Antigen-induced cellular immunogenicity may vary between populations due to differences in human leukocyte antigen (HLA) diversity and, hence, may play a critical role in the protection afforded by vaccines. In the setting of two, phase I/II human immunodeficiency virus-1 vaccine trials of a recombi...
Saved in:
Main Authors: | Paris R., Bejrachandra S., Karnasuta C., Chandanayingyong D., Kunachiwa W., Leetrakool N., Prakalapakorn S., Thongcharoen P., Nittayaphan S., Pitisuttithum P., Suriyanon V., Gurunathan S., McNeil J.G., Brown A.E., Birx D.L., De Souza M. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-4344678172&partnerID=40&md5=e2836f8624aefba8575ca63ff41ac0b7 http://cmuir.cmu.ac.th/handle/6653943832/3892 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
HLA class I serotypes and cytotoxic T-lymphocyte responses among human immunodeficiency virus-1-uninfected Thai volunteers immunized with ALVAC-HIV in combination with monomeric gp120 or oligomeric gp160 protein boosting
by: R. Paris, et al.
Published: (2018) -
A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost
by: Prasert Thongcharoen, et al.
Published: (2018) -
A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost
by: Prasert Thongcharoen, et al.
Published: (2018) -
Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand
by: Punnee Pitisuttithum, et al.
Published: (2018) -
The Potential of Camellia sinensis Extract to Prevent HIV/AIDS Transmission Risk Through the Inhibition of Syncytium, GP120, and GP41 Formation
by: Retno Pudji Rahayu, et al.
Published: (2019)